UBS Lux Equity Fund Biotech USD vs T. Rowe Price US Large Cap Growth Equity Fund A USD

UBS Lux Equity Fund Biotech USD vs T. Rowe Price US Large Cap Growth Equity Fund A USD

1. UBS Lux Equity Fund Biotech USD

  • Verdipapir

    UBS Lux Equity Fund Biotech USD P-acc

  • Gebyr

    2.25%

  • ISIN

    LU0069152568

  • Beholdninger

    10

2. T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Verdipapir

    T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Gebyr

    1.59%

  • ISIN

    LU0174119429

  • Beholdninger

    10

Fondsbeholdning

Vi har information om 14 beholdninger i UBS Lux Equity Fund Biotech USD, hvor den største beholdningen er Regeneron Pharmaceuticals (10.04%), etterfulgt av Vertex (9.35%) og Moderna (9.21%). Sammenligner vi med T. Rowe Price US Large Cap Growth Equity Fund A USD har vi der 20 beholdninger hvor Apple er største beholdningen (9.72%), etterfulgt av Microsoft (9.66%) og Nvidia (8.48%).

Alle beholdninger

Her sammenligner vi beholdningene i UBS Lux Equity Fund Biotech USD og T. Rowe Price US Large Cap Growth Equity Fund A USD.

UBS Lux Equity Fund Biotech USD T. Rowe Price US Large Cap Growth Equity Fund A USD
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Apple Inc
USA
9.72 %
2. Vertex Pharmaceuticals Inc
9.35 %
2. Microsoft Corp
USA
9.66 %
3. Moderna Inc
9.21 %
3. Nvidia Corp
USA
8.48 %
4. Alnylam Pharmaceuticals Inc
6.96 %
4. Amazon.com Inc
USA
7.9 %
5. AbbVie Inc
USA
5.53 %
5. Alphabet Inc Class A
USA
4.7 %
6. Gilead Sciences Inc
USA
4.66 %
6. Meta Platforms A
USA
4.66 %
7. Amgen Inc
4.3 %
7. Mastercard Inc
USA
3.72 %
8. BioNTech SE
4.13 %
8. Intuit Inc
3.31 %
9. Karuna Therapeutics Inc
3.75 %
9. ServiceNow Inc
USA
2.9 %
10. Royalty Pharma Plc
3.37 %
10. Visa Inc
USA
2.77 %

Listen over fondsbeholdning ble sist oppdatert 4 juni 2025.